Preoperative imaging for locoregional staging of bladder cancer

[1]  K. Harada,et al.  Diagnostic Accuracy and Interobserver Agreement for the Vesical Imaging-Reporting and Data System for Muscle-invasive Bladder Cancer: A Multireader Validation Study. , 2019, European urology.

[2]  Yan Guo,et al.  Multiparametric MRI for Bladder Cancer: Validation of VI-RADS for the Detection of Detrusor Muscle Invasion. , 2019, Radiology.

[3]  C. Catalano,et al.  Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center , 2019, European Radiology.

[4]  S. Silverman,et al.  Use of Quantitative T2-Weighted and Apparent Diffusion Coefficient Texture Features of Bladder Cancer and Extravesical Fat for Local Tumor Staging After Transurethral Resection. , 2019, AJR. American journal of roentgenology.

[5]  R. Epstein,et al.  Beyond BCG: the approaching era of personalised bladder-sparing therapies for non-muscle-invasive urothelial cancers. , 2019, Future oncology.

[6]  Christian B. van der Pol,et al.  Update on multiparametric MRI of urinary bladder cancer , 2018, Journal of magnetic resonance imaging : JMRI.

[7]  R. Huddart,et al.  Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). , 2018, European urology.

[8]  H. Merisaari,et al.  11C-acetate PET/MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial) , 2018, Cancer Imaging.

[9]  M. Nagi,et al.  Role of Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) in Assessment of Urinary Bladder Carcinoma , 2018, The Egyptian Journal of Hospital Medicine.

[10]  E. Abdelsalam,et al.  Value of diffusion weighted magnetic resonance imaging in grading of urinary bladder carcinoma , 2018, The Egyptian Journal of Radiology and Nuclear Medicine.

[11]  Steven L. Chang,et al.  Current Staging Strategies for Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Cell Carcinoma. , 2018, The Urologic clinics of North America.

[12]  Adam T Froemming,et al.  ACR Appropriateness Criteria® Pretreatment Staging of Muscle-Invasive Bladder Cancer. , 2018, Journal of the American College of Radiology.

[13]  Tianxin Lin,et al.  Computed tomography and magnetic resonance imaging evaluation of pelvic lymph node metastasis in bladder cancer , 2018, Chinese journal of cancer.

[14]  S. Silverman,et al.  Bladder cancer local staging: multiparametric MRI performance following transurethral resection , 2018, Abdominal Radiology.

[15]  P. Choyke,et al.  Advances in medical imaging for the diagnosis and management of common genitourinary cancers. , 2017, Urologic oncology.

[16]  Søren Høyer,et al.  Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Results from a High-volume Centre Including Long-term Follow-up. , 2017, European urology focus.

[17]  W. Horninger,et al.  Pelvic Lymph Node Staging by Combined 18F‐FDG‐PET/CT Imaging in Bladder Cancer Prior to Radical Cystectomy , 2017, Clinical genitourinary cancer.

[18]  M. Talaat,et al.  Can diffusion-weighted MRI predict the histological grade of urinary bladder carcinoma? , 2017 .

[19]  Cher Heng Tan,et al.  Role of Imaging in the Local Staging of Urothelial Carcinoma of the Bladder. , 2017, AJR. American journal of roentgenology.

[20]  Carlo Catalano,et al.  An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer , 2017, European Radiology.

[21]  Su-Jin Shin,et al.  Non-contrast magnetic resonance imaging for bladder cancer: fused high b value diffusion-weighted imaging and T2-weighted imaging helps evaluate depth of invasion , 2017, European Radiology.

[22]  C. Hofmeister,et al.  Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

[23]  Hao Sun,et al.  Quantitative CT texture analysis for evaluating histologic grade of urothelial carcinoma , 2017, Abdominal Radiology.

[24]  A. Zytoon,et al.  Role of magnetic resonance in evaluation of urinary bladder cancer , 2017 .

[25]  T. W. Kassem.  Up and down staging of TCC using 18F-FDG PET/CT scan , 2016 .

[26]  C. Yağcı,et al.  The Role of Computerized Tomography in the Assessment of Perivesical Invasion in Bladder Cancer , 2016, Polish journal of radiology.

[27]  F. Faeghi,et al.  Role of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Staging of Bladder Cancer. , 2016, Journal of clinical and diagnostic research : JCDR.

[28]  B. Haller,et al.  Prognostic value of computed tomography before radical cystectomy in patients with invasive bladder cancer: imaging predicts survival , 2016, World Journal of Urology.

[29]  P. Dahm,et al.  The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis , 2016, World Journal of Urology.

[30]  B. Haller,et al.  Evaluation of Computed Tomography for Lymph Node Staging in Bladder Cancer Prior to Radical Cystectomy , 2015, Urologia Internationalis.

[31]  I. Shabo,et al.  PET/CT versus conventional CT for detection of lymph node metastases in patients with locally advanced bladder cancer , 2015, BMC Urology.

[32]  O. Patschan,et al.  [18F]Fluorodeoxyglucose – positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy , 2015, Scandinavian journal of urology.

[33]  B. Sureka,et al.  Comparison of dynamic contrast-enhanced and diffusion weighted magnetic resonance image in staging and grading of carcinoma bladder with histopathological correlation , 2015, Urology annals.

[34]  P. Choyke,et al.  Lymph Node Staging in Prostate Cancer , 2015, Current Urology Reports.

[35]  D. Rubello,et al.  11C-Choline PET/CT and Bladder Cancer: Lymph Node Metastasis Assessment With Pathological Specimens as Reference Standard , 2015, Clinical nuclear medicine.

[36]  Choung-Soo Kim,et al.  FDG PET–CT for Lymph Node Staging of Bladder Cancer: A Prospective Study of Patients with Extended Pelvic Lymphadenectomy , 2015, Annals of Surgical Oncology.

[37]  S. Shariat,et al.  Prospective evaluation of diffusion-weighted MRI of the bladder as a biomarker for prediction of bladder cancer aggressiveness. , 2014, Urologic oncology.

[38]  W. See.  Commentary on "Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle." Mertens LS, Fioole-Bruining A, Vegt E, Vogel WV, van Rhijn BW, Horenblas S, Department of Urology, The Netherlands Can , 2014, Urologic oncology.

[39]  P. Dasgupta,et al.  Role of fluorodeoxyglucose positron emission tomography (FDG PET)‐computed tomography (CT) in the staging of bladder cancer , 2014, BJU international.

[40]  L. Bains,et al.  Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging. , 2014, Radiology.

[41]  Sam S. Chang,et al.  Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy , 2014, BJU international.

[42]  Jurgen J Fütterer,et al.  Multiparametric MRI of the bladder: ready for clinical routine? , 2014, AJR. American journal of roentgenology.

[43]  D. Rubello,et al.  Diagnostic Accuracy of 11C-Choline PET/CT in Preoperative Lymph Node Staging of Bladder Cancer: A Systematic Comparison With Contrast-Enhanced CT and Histologic Findings , 2014, Clinical nuclear medicine.

[44]  Maria Triantafyllou,et al.  Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer. , 2013, European urology.

[45]  Andrea Soricelli,et al.  Clinical impact of PET/MR imaging in patients with cancer undergoing same-day PET/CT: initial experience in 134 patients--a hypothesis-generating exploratory study. , 2013, Radiology.

[46]  Yuta Shibamoto,et al.  MR imaging of urinary bladder cancer for T‐staging: A review and a pictorial essay of diffusion‐weighted imaging , 2013, Journal of magnetic resonance imaging : JMRI.

[47]  S. Horenblas,et al.  Impact of 18F‐fluorodeoxyglucose (FDG)‐positron‐emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle , 2013, BJU international.

[48]  Yu Fan,et al.  Clinical value of T2-weighted imaging combined with diffusion-weighted imaging in preoperative T staging of urinary bladder cancer: a large-scale, multiobserver prospective study on 3.0-T MRI. , 2013, Academic radiology.

[49]  K. Renaudin,et al.  18F‐fluorodeoxyglucose positron emission tomography–computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: A prospective study , 2013, International journal of urology : official journal of the Japanese Urological Association.

[50]  M. Shakiba,et al.  Value of MRI in local staging of bladder cancer. , 2013, Urology journal.

[51]  R. Huddart,et al.  Advances in bladder cancer imaging , 2013, BMC Medicine.

[52]  Maria Triantafyllou,et al.  Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer. , 2013, European journal of cancer.

[53]  B. Nayak,et al.  Diuretic 18F-FDG PET/CT imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[54]  S. Daneshmand,et al.  Preoperative staging of invasive bladder cancer with dynamic gadolinium-enhanced magnetic resonance imaging: results from a prospective study. , 2012, Urology.

[55]  A. Scott,et al.  PET in prostate and bladder tumors. , 2012, Seminars in nuclear medicine.

[56]  A. Graser,et al.  Interobserver variability limits exact preoperative staging by computed tomography in bladder cancer. , 2012, Urology.

[57]  M. Schwaiger,et al.  Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy. , 2012, European urology.

[58]  O. Gofrit,et al.  11C-Acetate PET/CT in Bladder Urothelial Carcinoma: Intraindividual Comparison With 11C-Choline , 2012, Clinical nuclear medicine.

[59]  M. Gallucci,et al.  Diffusion‐weighted magnetic resonance imaging in patients selected for radical cystectomy: detection rate of pelvic lymph node metastases , 2012, BJU international.

[60]  S. Larson,et al.  Initial Results with 11C-Acetate Positron Emission Tomography/Computed Tomography (PET/CT) in the Staging of Urinary Bladder Cancer , 2012, Molecular Imaging and Biology.

[61]  K. Miles,et al.  Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. , 2012, Clinical radiology.

[62]  A Rajesh,et al.  Bladder cancer: evaluation of staging accuracy using dynamic MRI. , 2011, Clinical radiology.

[63]  J. Baniel,et al.  Comparison of 11C-choline with 18F-FDG in positron emission tomography/computerized tomography for staging urothelial carcinoma: a prospective study. , 2011, The Journal of urology.

[64]  O. Akin,et al.  Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in bladder cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[65]  L. Lacombe,et al.  Evaluation of fluorodeoxyglucose positron‐emission tomography with computed tomography for staging of urothelial carcinoma , 2010, BJU international.

[66]  Balaji Ganeshan,et al.  Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage , 2010, Cancer imaging : the official publication of the International Cancer Imaging Society.

[67]  A. Zlotta,et al.  Staging and Staging Errors in Bladder Cancer , 2010 .

[68]  A. Maes,et al.  FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer. , 2010, European urology.

[69]  Cary Siegel,et al.  Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  M. Kanematsu,et al.  Preoperative T staging of urinary bladder cancer: does diffusion-weighted MRI have supplementary value? , 2009, AJR. American journal of roentgenology.

[71]  Yuta Shibamoto,et al.  Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade. , 2009, Radiology.

[72]  S. Baltacı,et al.  Computerized Tomography for Detecting Perivesical Infiltration and Lymph Node Metastasis in Invasive Bladder Carcinoma , 2008, Urologia Internationalis.

[73]  S. Silverman,et al.  Bladder cancer detection with CT urography in an Academic Medical Center. , 2008, Radiology.

[74]  M. Picchio,et al.  Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[75]  L. Mortelmans,et al.  FDG-PET for preoperative staging of bladder cancer , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[76]  Jeong Kon Kim,et al.  Bladder cancer: analysis of multi-detector row helical CT enhancement pattern and accuracy in tumor detection and perivesical staging. , 2004, Radiology.

[77]  R. Yamada,et al.  Evaluation of 18F-FDG PET with bladder irrigation in patients with uterine and ovarian tumors. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[78]  M. Caterino,et al.  Primary cancer of the urinary bladder: CT evaluation of the T parameter with different techniques , 2001, Abdominal Imaging.

[79]  A. Jemal,et al.  Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[80]  Adam T Froemming,et al.  ACR Appropriateness Criteria® Pretreatment Staging of Muscle-Invasive Bladder Cancer. , 2018, Journal of the American College of Radiology : JACR.

[81]  A. Rosenkrantz,et al.  Prospective Pilot Study to Evaluate the Incremental Value of PET Information in Patients With Bladder Cancer Undergoing 18F-FDG Simultaneous PET/MRI , 2017, Clinical nuclear medicine.

[82]  H. Chandarana,et al.  Current Status of Hybrid PET/MRI in Oncologic Imaging. , 2016, AJR. American journal of roentgenology.

[83]  Rakesh Kumar,et al.  Diuretic 18F-Fluorodeoxyglucose PET/Computed Tomography in Evaluation of Genitourinary Malignancies. , 2016, PET clinics.

[84]  T. W. Kassem.  Up and down staging of TCC using 18 F-FDG PET / CT scan , 2016 .

[85]  V. Goh,et al.  Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival. , 2013, Radiology.

[86]  Michael R Hamblin,et al.  CA : A Cancer Journal for Clinicians , 2011 .

[87]  D. Bluemke,et al.  Dynamic MRI of bladder cancer: evaluation of staging accuracy. , 2005, AJR. American journal of roentgenology.

[88]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[89]  J. Cooper.  Ajcc Cancer Staging Manual , 1997 .